Crossref
4-Cholesten-3-one Modified the Lipidome of MDA-MB-231 Cells and Potentiated the Effect of Docetaxel
Anticancer Research · 2024
DOI: 10.21873/anticanres.17146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Sristy Saha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, UR2160 ISOMer, Nantes, France. Hauptthemen laut MEDLINE: Docetaxel, Lipidomics, Cell Movement, Cell Proliferation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
DocetaxelLipidomicsCell MovementCell ProliferationHumansCell Line, TumorFemaleCell SurvivalDrug SynergismBreast NeoplasmsAntineoplastic AgentsLipid MetabolismMDA-MB-231 Cells
Stichwörter der Autor:innen
4-cholesten-3-oneMDA-MB-231docetaxellipidomicslipogenesismigrationproliferation
Substanzen
DocetaxelAntineoplastic Agents
Autor:innen und Institutionen
- Nantes Université, UR2160 ISOMer, Nantes, France.
- CRNH-Ouest Mass Spectrometry Core Facility, Nantes, France.
- Nantes Université, CNRS, INSERM, Institut du Thorax, Nantes, France.
- Nantes Université, UR2160 ISOMer, Nantes, France; el-hassane.nazih@univ-nantes.fr.
Zitieren
APA
Saha, S., Croyal, M., Huvelin, J. M., & Nazih, H. (2024). 4-Cholesten-3-one Modified the Lipidome of MDA-MB-231 Cells and Potentiated the Effect of Docetaxel. Anticancer Research. https://doi.org/10.21873/anticanres.17146
Vancouver
Saha S, Croyal M, Huvelin JM, Nazih H. 4-Cholesten-3-one Modified the Lipidome of MDA-MB-231 Cells and Potentiated the Effect of Docetaxel. Anticancer Research. 2024. doi:10.21873/anticanres.17146
BibTeX
@article{Saha2024,
author = {Saha, Sristy and Croyal, Mikaël and Huvelin, Jean-Michel and Nazih, Hassan},
title = {4-Cholesten-3-one Modified the Lipidome of MDA-MB-231 Cells and Potentiated the Effect of Docetaxel},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17146}
}
EUVIMED